Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

Summary

The primary purpose of this study is to assess the effect of TX000045 on pulmonary vascular resistance (PVR) in participants with pulmonary hypertension secondary to interstitial lung disease (PH-ILD) and to assess the safety and tolerability of TX000045 in participants with PH-ILD.

Timeline

Start

2026-03-30

Primary completion

2027-11-21

Completion

2027-12-11

Drugs

Indications